Mitsubishi UFJ Trust & Banking’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.5M | Sell |
558,065
-38,626
| -6% | -$3.24M | 0.11% | 183 |
|
|
2026
Q1 | $47.8M | Sell |
596,691
-85,212
| -12% | -$7.03M | 0.12% | 171 |
|
|
2025
Q4 | $58.1M | Sell |
681,903
-125,516
| -16% | -$10.3M | 0.14% | 151 |
|
|
2025
Q3 | $62.8M | Sell |
807,419
-25,276
| -3% | -$1.97M | 0.14% | 161 |
|
|
2025
Q2 | $65.1M | Sell |
832,695
-223,792
| -21% | -$16.7M | 0.15% | 150 |
|
|
2025
Q1 | $76.6M | Sell |
1,056,487
-55,349
| -5% | -$3.96M | 0.2% | 111 |
|
|
2024
Q4 | $82.3M | Sell |
1,111,836
-437,338
| -28% | -$30.6M | 0.19% | 112 |
|
|
2024
Q3 | $102M | Buy |
1,549,174
+20,756
| +1% | +$1.51M | 0.23% | 91 |
|
|
2024
Q2 | $141M | Sell |
1,528,418
-32,284
| -2% | -$2.86M | 0.34% | 58 |
|
|
2024
Q1 | $148M | Sell |
1,560,702
-75,100
| -5% | -$6.31M | 0.34% | 64 |
|
|
2023
Q4 | $125M | Buy |
1,635,802
+42,294
| +3% | +$2.94M | 0.29% | 76 |
|
|
2023
Q3 | $110M | Buy |
1,593,508
+172,707
| +12% | +$13.9M | 0.28% | 82 |
|
|
2023
Q2 | $134M | Buy |
1,420,801
+213,448
| +18% | +$18.6M | 0.31% | 71 |
|
|
2023
Q1 | $99.9M | Buy |
1,207,353
+294,877
| +32% | +$23.2M | 0.24% | 100 |
|
|
2022
Q4 | $68.1M | Buy |
912,476
+24,485
| +3% | +$1.89M | 0.18% | 135 |
|
|
2022
Q3 | $73.4M | Sell |
887,991
-56,817
| -6% | -$5.47M | 0.21% | 115 |
|
|
2022
Q2 | $89.8M | Buy |
944,808
+31,590
| +3% | +$3.27M | 0.23% | 101 |
|
|
2022
Q1 | $108M | Sell |
913,218
-176,814
| -16% | -$19.8M | 0.25% | 99 |
|
|
2021
Q4 | $141M | Sell |
1,090,032
-42,041
| -4% | -$4.9M | 0.29% | 86 |
|
|
2021
Q3 | $128M | Sell |
1,132,073
-315,347
| -22% | -$36M | 0.28% | 87 |
|
|
2021
Q2 | $150M | Sell |
1,447,420
-59,415
| -4% | -$5.6M | 0.32% | 73 |
|
|
2021
Q1 | $131M | Sell |
1,506,835
-115,808
| -7% | -$9.79M | 0.29% | 82 |
|
|
2020
Q4 | $148M | Buy |
1,622,643
+17,442
| +1% | +$1.45M | 0.3% | 72 |
|
|
2020
Q3 | $128M | Buy |
1,605,201
+114,533
| +8% | +$8.94M | 0.29% | 81 |
|
|
2020
Q2 | $103M | Buy |
1,490,668
+479,446
| +47% | +$34.1M | 0.25% | 97 |
|
|
2020
Q1 | $63.6M | Buy |
1,011,222
+447,993
| +80% | +$32.3M | 0.19% | 127 |
|
|
2019
Q4 | $43.8M | Sell |
563,229
-6,054
| -1% | -$473K | 0.1% | 218 |
|
|
2019
Q3 | $41.2M | Sell |
569,283
-8,286
| -1% | -$582K | 0.11% | 226 |
|
|
2019
Q2 | $35.7M | Buy |
577,569
+62,190
| +12% | +$3.76M | 0.12% | 203 |
|
|
2019
Q1 | $32.4M | Sell |
515,379
-333
| -0.1% | -$19K | 0.12% | 214 |
|
|
2018
Q4 | $26.3M | Sell |
515,712
-8,565
| -2% | -$433K | 0.11% | 222 |
|
|
2018
Q3 | $30.4M | Sell |
524,277
-773,895
| -60% | -$37.8M | 0.11% | 227 |
|
|
2018
Q2 | $63M | Sell |
1,298,172
-63,252
| -5% | -$2.95M | 0.11% | 214 |
|
|
2018
Q1 | $63.3M | Buy |
1,361,424
+9,780
| +0.7% | +$425K | 0.11% | 211 |
|
|
2017
Q4 | $50.8M | Buy |
1,351,644
+69,135
| +5% | +$2.54M | 0.09% | 257 |
|
|
2017
Q3 | $46.7M | Sell |
1,282,509
-7,764
| -0.6% | -$296K | 0.09% | 265 |
|
|
2017
Q2 | $50.9M | Sell |
1,290,273
-7,608
| -0.6% | -$278K | 0.1% | 241 |
|
|
2017
Q1 | $40.7M | Buy |
1,297,881
+729
| +0.1% | +$22.8K | 0.08% | 286 |
|
|
2016
Q4 | $40.5M | Sell |
1,297,152
-28,020
| -2% | -$908K | 0.09% | 270 |
|
|
2016
Q3 | $53.3M | Buy |
1,325,172
+7,335
| +0.6% | +$276K | 0.11% | 222 |
|
|
2016
Q2 | $43.8M | Buy |
1,317,837
+45,990
| +4% | +$1.57M | 0.1% | 254 |
|
|
2016
Q1 | $37.4M | Buy |
1,271,847
+7,779
| +0.6% | +$215K | 0.08% | 278 |
|
|
2015
Q4 | $33.3M | Sell |
1,264,068
-1,842
| -0.1% | -$47.8K | 0.08% | 299 |
|
|
2015
Q3 | $30M | Buy |
1,265,910
+15,408
| +1% | +$372K | 0.07% | 314 |
|
|
2015
Q2 | $29.7M | Buy |
1,250,502
+33,792
| +3% | +$763K | 0.07% | 332 |
|
|
2015
Q1 | $28.9M | Buy |
1,216,710
+46,266
| +4% | +$1.04M | 0.07% | 339 |
|
|
2014
Q4 | $24.8M | Buy |
1,170,444
+17,442
| +2% | +$350K | 0.06% | 373 |
|
|
2014
Q3 | $19.6M | Sell |
1,153,002
-89,790
| -7% | -$1.42M | 0.05% | 428 |
|
|
2014
Q2 | $17.8M | Buy |
1,242,792
+1,026
| +0.1% | +$13.9K | 0.04% | 473 |
|
|
2014
Q1 | $15.3M | Sell |
1,241,766
-18,522
| -1% | -$214K | 0.04% | 497 |
|
|
2013
Q4 | $13.8M | Sell |
1,260,288
-32,586
| -3% | -$367K | 0.03% | 539 |
|
|
2013
Q3 | $15M | Buy |
1,292,874
+12,612
| +1% | +$148K | 0.04% | 487 |
|
|
2013
Q2 | $14.3M | Buy |
+1,280,262
| New | +$15.2M | 0.04% | 468 |
|
Other funds holding EW
Mitsubishi UFJ Trust & Banking's EW Position: Q2 2026 in Review
Mitsubishi UFJ Trust & Banking reduced its Edwards Lifesciences (EW) stake by 6.5% in Q2 2026, selling an estimated $3.24M and leaving 558,065 shares worth $50.5M. The position accounts for 0.11% of the portfolio, ranked #183.
Mitsubishi UFJ Trust & Banking first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $150M in Q2 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Mitsubishi UFJ Trust & Banking held 558,065 shares of Edwards Lifesciences worth $50.5M as of Q2 2026.
- Mitsubishi UFJ Trust & Banking sold 38,626 Edwards Lifesciences shares in Q2 2026, an estimated $3.24M.
- Edwards Lifesciences made up 0.11% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #183 holding.
- Mitsubishi UFJ Trust & Banking first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Mitsubishi UFJ Trust & Banking's Edwards Lifesciences position peaked at $150M in Q2 2021.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.